The NHS in England is introducing a more efficient way of administering a treatment for HER2 positive early and metastatic breast cancer.  The new treatment is called Phesgo and is a combination of Perjeta (pertuzumab) and Herceptin (trastuzumab), two monoclonal … Continue reading →

Nice, the National Institute for Health and Care Excellence, has recommended the use of ribociclib, also known as Kisqali for routine use by the NHS in England and Wales, after it was originally made available through the Cancer Drugs Fund.  … Continue reading →

Dr Coffelt and his team at the Beatson Institute of the University of Glasgow are investigating the role of a type of immune cell called gamma delta T cells in helping breast cancer spread through the body and received grants … Continue reading →

Dr Pors and his team at the Institute of Cancer Therapeutics at the University of Bradford received a grant from Secondary1st in October 2019, but the lab was closed for a large part of 2020.  To mark World Cancer Day … Continue reading →

NHS England has announced that it is rolling out a new blood test which aims to detect whether some cancer patients are genetically prone to experience more serious effects from some chemotherapy treatments.  These treatments can then be tailored more … Continue reading →

Sharon was 45 when she was diagnosed with stage 3 breast cancer. She was immediately booked in for a single mastectomy, followed by a course of chemo sessions and radiotherapy. On the day of her surgery when she came round … Continue reading →

Thanks to our wonderful Donors and Fundraisers Secondary1st has been able to make a second grant of  £65,000 to the research project led by Dr Seth Coffelt at the Beatson Institute at the University of Glasgow.   Dr Coffelt and his … Continue reading →